InsidersTradesSigma
Track the 넥스트바이오메디컬 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 넥스트바이오메디컬 has published 1 reports. Market capitalisation: €281.8bn. The latest transaction was filed on 11 March 2026 (Other). Among the most active insiders: 넥스트바이오메디컬. Every trade is openly available.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
넥스트바이오메디컬 es una empresa que cotiza en el mercado XKRX, especializada en el sector de la salud y farmacéutico. Se enfoca en el desarrollo de soluciones innovadoras para mejorar la atención médica.